Correction: TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis

Correction: TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis

Saved in:

Bibliographic Details
Main Authors:	Jin Li, Ling Bai, Zhaodan Xin, Jiajia Song, Hao Chen, Xingbo Song, Juan Zhou
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-025-08641-8
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01)

Machine learning-based ultrasound radiomics for predicting TP53 mutation status in hepatocellular carcinoma
by: Didi Bu, et al.
Published: (2025-04-01)

p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms
by: Junjie Li, et al.
Published: (2021-01-01)

TP63 as a modulator of ferroptosis in TP53 mutations glioblastoma
by: Haiping Cai, et al.
Published: (2025-08-01)

A systematic analysis of the network of lncRNAs and mRNAs regulated by TP53 and TP53 mutants with hotspot mutations
by: Hong Chen, et al.
Published: (2025-07-01)

TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas
by: Lingling Wang, et al.
Published: (2024-07-01)

<i>TP53</i> Mutations in Chagasic Megaesophagus
by: Aparecida Perpetuo Fedossi Silveira, et al.
Published: (2025-03-01)

TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
by: Ugo Testa, et al.
Published: (2023-06-01)

TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization
by: Ken Zhao, et al.
Published: (2025-01-01)

Plasma ctDNA TP53 Mutation and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis
by: FAN Hao, et al.
Published: (2025-07-01)

FKBP10 expression and TP53 mutation predict prognosis and chemotherapy response in triple-negative breast cancer
by: Yan Li, et al.
Published: (2025-07-01)

Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
by: Regina Mirgayazova, et al.
Published: (2024-12-01)

TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas
by: Yingao Zhang, et al.
Published: (2025-08-01)

Insights into an uncommon case: axillary extramammary Paget’s disease and TP53 mutation
by: Julia Zawistowska, et al.
Published: (2025-01-01)

Essential thrombocytosis transformed AML with TP53 mutations and its clinical implications
by: Yang Si, et al.
Published: (2024-12-01)

Mosaic TP53 Mutation on Tumour Development in Pigs: A Case Study
by: Chommanart Thongkittidilok, et al.
Published: (2023-01-01)

HCV-related hepatocellular carcinoma: gene signatures associated with TERT promoter mutations and sex
by: Patrizia Bonelli, et al.
Published: (2025-06-01)

Predictive Value of IDEAL-IQ and DWI Imaging Biomarkers for P53 Mutations in Hepatocellular Carcinoma
by: Wang D, et al.
Published: (2025-08-01)

TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas
by: AE Misyurina, et al.
Published: (2019-05-01)

The relationship between TP53 Gene Mutation with treatment results in High-Grade Gliomas
by: Bac Thanh Nguyen, et al.
Published: (2024-05-01)

Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma
by: Xiaoyan Tang, et al.
Published: (2024-12-01)

Molecular characteristics and clinical implications of TP53 mutations in therapy-related myelodysplastic syndromes
by: Zefei Bao, et al.
Published: (2025-04-01)

Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome
by: Mingyuan Du, et al.
Published: (2024-12-01)

What have we learned about TP53-mutated acute myeloid leukemia?
by: Moazzam Shahzad, et al.
Published: (2024-11-01)

Differences in Gender and Overall Survival for Temperature-Sensitive TP53 Mutations in Gastroesophageal Cancer
by: Danial H. Shaikh, et al.
Published: (2024-11-01)

Pathogenic TP53 mutations influence chemotherapy response and survival rate of HPV-negative oral carcinomas
by: Jović Saša, et al.
Published: (2022-01-01)

Pathology of Hepatocellular Carcinoma and Tumor-Bearing Liver Tissue in Association with hTERT Promoter Mutation
by: Anne Kristin Fischer, et al.
Published: (2023-01-01)

DDX21 Is a Potential Biomarker for Predicting Recurrence and Prognosis in Hepatocellular Carcinoma
by: Chengjie Ji, et al.
Published: (2025-01-01)

Identification of a potential prognostic panel of biomarkers for stratification of head and neck squamous cell carcinoma based on HPV status and TP53 mutational status
by: Oriana Barros, et al.
Published: (2023-03-01)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
by: Masaya Kai, et al.
Published: (2022-10-01)

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations
by: Anmol Baranwal, et al.
Published: (2025-07-01)

LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations
by: Suzeng Wang, et al.
Published: (2025-02-01)

Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block
by: Jiexian Ma, et al.
Published: (2025-02-01)

CASES OF DIFFUSE LARGE B-CELL LYMPHOMA WITH FUNCTIONAL INTRON MUTATIONS IN THE TP53 GENE
by: E. N. Voropaeva, et al.
Published: (2020-03-01)

TP53-mutated MDS and AML: immune dysregulation, tumor microenvironment, and emerging therapeutic strategies
by: Marwah M. Albakri, et al.
Published: (2025-08-01)

Detection of Mutations in Exon 8 of TP53 by Temperature Gradient 96-Capillary Array Electrophoresis
by: A. Torgunrud Kristensen, et al.
Published: (2002-09-01)

Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
by: Juliana Giacomazzi, et al.
Published: (2014-01-01)

Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
by: Gelan Zhu, et al.
Published: (2024-12-01)

BRAFV600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression
by: Nguyen Thi Nhung, et al.
Published: (2025-07-01)

CircTP53/USP10/p53 signaling Axis as a Novel Regulator of Progression and Prognosis of Head and Neck Squamous Cell Carcinoma
by: Yin Wang, et al.
Published: (2025-08-01)